treatment
-
Sleep Health
FDA Grants Fast Track Designation to Lu AH69593 for the Treatment of Narcolepsy
The United States Food and Drug Administration (FDA) has officially granted Fast Track designation to Lu AH69593, an investigational oral…
Read More » -
Sleep Health
FDA Grants Fast Track Designation to Lundbeck’s Lu AH69593 for the Treatment of Narcolepsy
The pharmaceutical industry and the sleep medicine community are closely monitoring a significant regulatory development as H. Lundbeck A/S (Lundbeck)…
Read More » -
Aging and Longevity
King’s College London Researchers Identify Potential Breakthrough in Alzheimer’s Treatment Through Multi-Targeted Drug KCL-286
In a significant advancement for neurodegenerative research, a team of scientists at King’s College London has unveiled a novel therapeutic…
Read More » -
Aging and Longevity
King’s College London Researchers Identify Potential Breakthrough in Alzheimer’s Treatment Through Dual-Action Drug KCL-286
In a significant advancement for neurodegenerative research, a team of scientists at King’s College London (KCL) has identified a promising…
Read More » -
Holistic and Alternative Medicine
Lyme Disease: Beyond the Tick Bite and Bullseye Rash – A Deeper Dive into Diagnosis and Treatment
Lyme disease, often simplified in public perception to a single tick bite, a characteristic rash, and a course of antibiotics,…
Read More » -
Aging and Longevity
King’s College London Researchers Identify Breakthrough Multi-Target Drug Candidate KCL-286 for Early Stage Alzheimer’s Treatment
In a significant departure from traditional amyloid-centric research, a team of neuroscientists at King’s College London (KCL) has unveiled a…
Read More »
